Lehigh Valley Topper Cancer Institute
Where what’s next happens
Jefferson and LVHN sign a definitive agreement to combine.
Jefferson y LVHN firman acuerdo definitivo para unirse.
In the battle against cancer, you want every available weapon on your side. To help provide you with the most advanced cancer care, Lehigh Valley Topper Cancer Institute is a member of the Memorial Sloan Kettering (MSK) Cancer Alliance so we take your cancer fight to a new level. Cancer Institute patients have access to MSK clinical trials, which accelerates the data-collection process so investigational treatments can be approved faster and become available to more patients. Lehigh Valley Topper Cancer Institute is currently participating in elite cancer trials, including:
Targeted Agent and Profiling Utilization Registry (TAPUR)
Affiliated with the federal government’s Cancer Moonshot program to accelerate cancer research, the TAPUR study provides eligible patients with medication not yet approved by the FDA for their particular cancer type and collects data on the clinical response. Lehigh Valley Topper Cancer Institute is one of only two TAPUR sites in Pennsylvania.
Find out more information about these clinical research trials and additional research opportunities at Lehigh Valley Topper Cancer Institute: